Perrigo Reports In-Line Q2 EPS
- ByInvesting.com-
Perrigo (PRGO) reported Q2 EPS of $0.43, in-line with the analyst estimate of $0.43. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.06...
Perrigo (PRGO) reported Q2 EPS of $0.43, in-line with the analyst estimate of $0.43. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.06...
By Jessica DiNapoli NEW YORK (Reuters) -Target Corp has begun carrying Bobbie brand infant formula in some stores this week and the vast majority of its locations will be selling...
By Sam BougheddaConsumer self-care products firm Perrigo Company (NYSE:PRGO) announced Monday that its subsidiary, HRA Pharma, has submitted an application to the United States...
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund...
Equity investors will likely seek direction after Friday's disappointing August jobs report amid surging COVID-19 cases in the US, adding another layer of uncertainty to the...
Perrigo (PRGO) came out with quarterly earnings of $0.50 per share, missing the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $1.03 per share a year...
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S) and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies, and e-commerce channels.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Neutral | Sell | Neutral | Sell |
Technical Indicators | Buy | Strong Sell | Buy | Buy | Sell |
Summary | Buy | Sell | Neutral | Neutral | Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
8.14 | 8.15 | 7.85 | -0.22 | -2.62% | 3.61M | NYSE | |||
4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
31.85 | 31.88 | 30.71 | -0.90 | -2.75% | 4.48M | NYSE | |||
1.165 | 1.19 | 1.15 | -0.0450 | -3.72% | 1.71M | NYSE | |||
1.09 | 1.09 | 1.05 | -0.0100 | -0.91% | 81.22K | NYSE | |||
45.46 | 45.49 | 44.78 | -0.80 | -1.73% | 1.17M | NYSE | |||
3.54 | 3.55 | 3.47 | -0.060 | -1.67% | 7.83M | NYSE | |||
20.39 | 20.52 | 19.80 | +0.27 | +1.34% | 702.16K | NASDAQ | |||
7.44 | 7.54 | 6.73 | +0.570 | +8.30% | 4.41M | NYSE | |||
14.33 | 15.06 | 13.37 | +1.38 | +10.67% | 77.59M | NASDAQ | |||
49.77 | 49.85 | 47.44 | -1.12 | -2.19% | 1.49M | NYSE | |||
15.24 | 15.30 | 15.00 | +0.03 | +0.16% | 1.60M | OTC Markets | |||
0.78 | 0.79 | 0.776 | -0.010 | -1.27% | 5.42K | NASDAQ | |||
0.0006 | 0.0006 | 0.0006 | 0.00000 | 0.00% | 0.00 | OTC Markets | |||
42.83 | 42.85 | 42.42 | -0.68 | -1.56% | 1.82M | NYSE |